Manalo, Baby Girl .
HRN: 24-76-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/04/2024
06/10/2024
IVTT
100mg
Q24h
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes